Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric derisomaltose dosing in women of childbearing age with iron deficiency anemia
ChiCTR2200064994Phase 4Not yet recruiting
- Sponsor
- Baoshan Hospital of Shanghai University of Traditional Chinese Medicine
- Start
- Oct 2022
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of ferric derisomaltose in iron deficiency anemia (IDA) (2 arms), sponsored by Baoshan Hospital of Shanghai University of Traditional Chinese Medicine. Primary endpoints: Hemoglobin, Serum ferritin and 1 more. Planned start Oct 2022; status: not yet recruiting.
02
Drugs
ferric derisomaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on ChiCTR2200064994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200064994.